Adiponectin and bone mass density: The InCHIANTI study

Bone

Volumn 47, Issue 6, 2010, Pages 1001-1005

  Napoli, Nicola ^a,b   Pedone, Claudio ^a   Pozzilli, Paolo ^a   Lauretani, Fulvio ^c   Ferrucci, Luigi ^d   Incalzi, Raffaele Antonelli ^a,e  

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^b WASHINGTON UNIVERSITY   (United States)

^c Tuscany Regional Health Agency   (Italy)

^d NATIONAL INSTITUTE ON AGING   (United States)

^e Fondazione San Raffaele   (Italy)

Author keywords

Adiponectin; Bone mass; PQCT

Indexed keywords

ADIPONECTIN;

ADULT; AGE DISTRIBUTION; AGED; ALCOHOL CONSUMPTION; ANTHROPOMETRY; ARTICLE; BIOIMPEDENZIOMETRY; BODY COMPOSITION; BODY DENSITY; BODY FAT; BONE MASS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATION COEFFICIENT; CORTICAL BONE; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; POSTMENOPAUSE; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; RADIOIMMUNOASSAY; SEX DIFFERENCE; SMOKING; TRABECULAR BONE;

ADIPONECTIN; ADULT; AGED; AGED, 80 AND OVER; BODY COMPOSITION; BONE DENSITY; CONFOUNDING FACTORS (EPIDEMIOLOGY); FEMALE; HUMANS; ITALY; MALE; MIDDLE AGED; REGRESSION ANALYSIS;

EID: 78049434675     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2010.08.010     Document Type: Article

References (48)

1. Reid I.R., Ames R., Evans M.C., Sharpe S., Gamble G., France J.T., et al. Determinants of total body and regional bone mineral density in normal postmenopausal women-a key role for fat mass. J Clin Endocrinol Metab 1992, 75:45-51.
2. Zhao L.J., Jiang H., Papasian C.J., Maulik D., Drees B., Hamilton J., et al. Correlation of obesity and osteoporosis: effect of fat mass on the determination of osteoporosis. J Bone Miner Res 2008, 23:17-29.
3. Reid I.R. Relationships among body mass, its components, and bone. Bone 2002, 31:547-555.
4. Mantzoros C.S. The role of leptin in human obesity and disease: a review of current evidence. Ann Intern Med 1999, 130:671-680.
5. Rosen C.J., Bouxsein M.L. Mechanisms of disease: is osteoporosis the obesity of bone?. Nat Clin Pract Rheumatol 2006, 2:35-43.
6. Elefteriou F., Ahn J.D., Takeda S., Starbuck M., Yang X., Liu X., et al. Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature 2005, 434:514-520.
7. Takeda S., Elefteriou F., Levasseur R., Liu X., Zhao L., Parker K.L., et al. Leptin regulates bone formation via the sympathetic nervous system. Cell 2002, 111:305-317.
8. Combs T.P., Berg A.H., Obici S., Scherer P.E., Rossetti L. Endogenous glucose production is inhibited by the adipose-derived protein Acrp30. J Clin Invest 2001, 108:1875-1881.
9. Berg A.H., Combs T.P., Du X., Brownlee M., Scherer P.E. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med 2001, 7:947-953.
10. Kadowaki T., Yamauchi T. Adiponectin and adiponectin receptors. Endocr Rev 2005, 26:439-451.
11. Kharroubi I., Rasschaert J., Eizirik D.L., Cnop M. Expression of adiponectin receptors in pancreatic beta cells. Biochem Biophys Res Commun 2003, 312:1118-1122.
12. Williams G.A., Wang Y., Callon K.E., Watson M., Lin J.M., Lam J.B.B., Costa J.L., Orpe A., Broom N., Naot D., Reid I.R., Cornish J. In vitro and in vivo effects of adiponectin on bone. Endocrinology 2009, 150:3603-3610.
13. Weyer C., Funahashi T., Tanaka S., Hotta K., Matsuzawa Y., Pratley R.E., et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001, 86:1930-1935.
14. Pischon T., Girman C.J., Hotamisligil G.S., Rifai N., Hu F.B., Rimm E.B. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 2004, 291:1730-1737.
15. Nakashima R., Kamei N., Yamane K., Nakanishi S., Nakashima A., Kohno N. Decreased total and high molecular weight adiponectin are independent risk factors for the development of type 2 diabetes in Japanese-Americans. J Clin Endocrinol Metab 2006, 91:3873-3877.
16. Shinoda Y., Yamaguchi M., Ogata N., Akune T., Kubota N., Yamauchi T., et al. Regulation of bone formation by adiponectin through autocrine/paracrine and endocrine pathways. J Cell Biochem 2006, 99:196-208.
17. Oshima K., Nampei A., Matsuda M., Iwaki M., Fukuhara A., Hashimoto J., et al. Adiponectin increases bone mass by suppressing osteoclast and activating osteoblast. Biochem Biophys Res Commun 2005, 331:520-526.
18. Lenchik L., Register T.C., Hsu F.C., Lohman K., Nicklas B.J., Freedman B.I., et al. Adiponectin as a novel determinant of bone mineral density and visceral fat. Bone 2003, 33:646-651.
19. Richards J.B., Valdes A.M., Burling K., Perks U.C., Spector T.D. Serum adiponectin and bone mineral density in women. J Clin Endocrinol Metab 2007, 92:1517-1523.
20. Jürimäe J., Rembel K., Jürimäe T., Rehand M. Adiponectin is associated with bone mineral density in perimenopausal women. Horm Metab Res 2005, 37:297-302.
21. Michaëlsson K., Lind L., Frystyk J., Flyvbjerg A., Gedeborg R., Berne C., et al. Serum adiponectin in elderly men does not correlate with fracture risk. J Clin Endocrinol Metab 2008, 93:4041-4047.
22. Zoico E., Zamboni M., Francesco V.D., Mazzali G., Fantin F., Pergola G.D., et al. Relation between adiponectin and bone mineral density in elderly post-menopausal women: role of body composition, leptin, insulin resistance, and dehydroepiandrosterone sulfate. J Endocrinol Invest 2008, 31:297-302.
23. Yatagai T., Nagasaka S., Taniguchi A., Fukushima M., Nakamura T., Kuroe A., et al. Hypoadiponectinemia is associated with visceral fat accumulation and insulin resistance in Japanese men with type 2 diabetes mellitus. Metabolism 2003, 52:1274-1278.
24. Ferrucci L., Bandinelli S., Benvenuti E., Iorio A.D., Macchi C., Harris T.B., et al. Subsystems contributing to the decline in ability to walk: bridging the gap between epidemiology and geriatric practice in the InCHIANTI study. J Am Geriatr Soc 2000, 48:1618-1625.
25. Rittweger J., Michaelis I., Giehl M., Wüsecke P., Felsenberg D. Adjusting for the partial volume effect in cortical bone analyses of pQCT images. J Musculoskelet Neuronal Interact Dec 2004, 4(4):436-441.
26. Sornay-Rendu E., Boutroy S., Munoz F., Bouxsein M.L. Cortical and trabecular architecture are altered in postmenopausal women with fractures. Osteoporos Int 2009, 20:1291-1297.
27. Vico L., Zouch M., Amirouche A., Frère D., Laroche N., Koller B., et al. High-resolution pQCT analysis at the distal radius and tibia discriminates patients with recent wrist and femoral neck fractures. J Bone Miner Res 2008, 23:1741-1750.
28. Russo C.R., Lauretani F., Seeman E., Bartali B., Bandinelli S., Di Iorio A., et al. Structural adaptations to bone loss in aging men and women. Bone Jan 2006, 38(1):112-118.
29. Lauretani F., Bandinelli S., Russo C.R., Maggio M., Di Iorio A., Cherubini A., et al. Correlates of bone quality in older persons. Bone Oct 2006, 39(4):915-921.
30. Riboli E., Hunt K.J., Slimani N., Ferrari P., Norat T., Fahey M., et al. European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr 2002, 5:1113-1124.
31. Kontogianni M.D., Dafni U.G., Routsias J.G., Skopouli F.N. Blood leptin and adiponectin as possible mediators of the relation between fat mass and BMD in perimenopausal women. J Bone Miner Res 2004, 19:546-551.
32. Chanprasertyothin S., Saetung S., Payattikul P., Rajatanavin R., Ongphiphadhanakul B. Relationship of body composition and circulatory adiponectin to bone mineral density in young premenopausal women. J Med Assoc Thai 2006, 89:1579-1583.
33. Oh K.W., Lee W.Y., Rhee E.J., Baek K.H., Yoon K.H., Kang M.I., et al. The relationship between serum resistin, leptin, adiponectin, ghrelin levels and bone mineral density in middle-aged men. Clin Endocrinol (Oxf) 2005, 63:131-138.
34. Gonnelli S., Caffarelli C., Santo K.D., Cadirni A., Guerriero C., Lucani B., et al. The relationship of ghrelin and adiponectin with bone mineral density and bone turnover markers in elderly men. Calcif Tissue Int 2008, 83:55-60.
35. Araneta M.R.G., von Mühlen D., Barrett-Connor E. Gender differences in the association between adiponectin and bone mineral density, bone loss and fractures: the Rancho Bernardo Study. J Bone Miner Res 2009, 24(12):2016-2022.
36. Sievänen H., Koskue V., Rauhio A., Kannus P., Heinonen A., Vuori I. Peripheral quantitative computed tomography in human long bones: evaluation of in vitro and in vivo precision. J Bone Miner Res 1998, 13:871-882.
37. Schaffler M.B., Burr D.B. Stiffness of compact bone: effects of porosity and density. J Biomech 1988, 21(1):13-16.
38. Holzer G., von Skrbensky G., Holzer L.A., Pichl W. Hip fractures and the contribution of cortical versus trabecular bone to femoral neck strength. J Bone Miner Res Mar 2009, 24(3):468-474.
39. Rockoff S.D., Sweet E., Bleustein J. The relative contribution of trabecular and cortical bone to the strength of human lumbar vertebrae. Calcif Tissue Res 1969, 3(2):163-175.
40. Luo X.H., Zhao L.L., Yuan L.Q., Wang M., Xie H., Liao E.Y. Development of arterial calcification in adiponectin-deficient mice: adiponectin regulates arterial calcification. J Bone Miner Res Aug 2009, 24(8):1461-1468.
41. Combs T.P., Berg A.H., Rajala M.W., Klebanov S., Iyengar P., Jimenez-Chillaron J.C., et al. Sexual differentiation, pregnancy, calorie restriction, and aging affect the adipocyte-specific secretory protein adiponectin. Diabetes 2003, 52:268-276.
42. Kunnari A., Santaniemi M., Jokela M., Karjalainen A.H., Heikkinen J., Ukkola O., et al. Estrogen replacement therapy decreases plasma adiponectin but not resistin in postmenopausal women. Metabolism 2008, 57:1509-1515.
43. Page S.T., Herbst K.L., Amory J.K., Coviello A.D., Anawalt B.D., Matsumoto A.M., et al. Testosterone administration suppresses adiponectin levels in men. J Androl 2005, 26:85-92.
44. Wade G.N., Gray J.M., Bartness T.J. Gonadal influences on adiposity. Int J Obes 1985, 9(Suppl 1):83-92.
45. Luo X.H., Guo L.J., Yuan L.Q., Xie H., Zhou H.D., Wu X.P., et al. Adiponectin stimulates human osteoblasts proliferation and differentiation via the MAPK signaling pathway. Exp Cell Res 2005, 309:99-109.
46. Yamaguchi N., Kukita T., Li Y.J., Argueta J.G.M., Saito T., Hanazawa S., et al. Adiponectin inhibits osteoclast formation stimulated by lipopolysaccharide from Actinobacillus actinomycetemcomitans. FEMS Immunol Med Microbiol 2007, 49:28-34.
47. Hangartner T.N., Gilsanz V. Evaluation of cortical bone by computed tomography. J Bone Miner Res Oct 1996, 11(10):1518-1525.
48. Pajvani U.B., Du X., Combs T.P., Berg A.H., Rajala M.W., Schulthess T., et al. Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications fpr metabolic regulation and bioactivity. J Biol Chem 2003, 278:9073-9085.